IP Law Podcast: Christopher Loh of Fitzpatrick Cella Harper & Scinto in New York City discusses the Amgen v. Sanofi CAFC decision and his paper “End of ‘well characterized antigen’ test?”

November 6, 2018

Subscribe to our newsletter

You can unsubscribe at any time. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

This site is registered on as a development site.